SLEEP OUTCOMES FROM AWAKE-HF, A RANDOMIZED CLINICAL TRIAL WITH OPEN-LABEL EXTENSION OF SACUBITRIL/VALSARTAN VERSUS ENALAPRIL IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
2019
The AWAKE-HF study evaluated the effect of sacubitril/valsartan (S/V) versus enalapril on sleep using actigraphy and a home sleep study in patients (pts) with heart failure with reduced ejection fraction (HFrEF).
Pts 18 to 80 years of age with New York Heart Association (NYHA) class II/III HFrEF
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI